tiprankstipranks
Trending News
More News >
OncoArendi Therapeutics SA (DE:1B1)
FRANKFURT:1B1
Germany Market
Advertisement

OncoArendi Therapeutics SA (1B1) Income Statement

Compare
0 Followers

OncoArendi Therapeutics SA Income Statement

Last quarter (Q1 2025), OncoArendi Therapeutics SA's total revenue was zł0.00, a decrease of -100.00% from the same quarter last year. In Q1, OncoArendi Therapeutics SA's net income was zł-5.18M. See OncoArendi Therapeutics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
zł 0.00zł 100.00zł 1.61Mzł 400.00zł 122.94M
Gross Profit
zł 0.00zł -4.10Mzł -21.33Kzł -2.77Mzł 84.53M
Operating Expenses
zł 29.79Mzł 7.47Mzł 15.35Mzł 10.99Mzł 10.83M
Depreciation and Amortization
zł 3.82Mzł 2.83Mzł 3.98Mzł 299.82Kzł 218.37K
EBITDA
zł -27.37Mzł -25.51Mzł -31.85Mzł -13.33Mzł 73.88M
Operating Income
zł -33.61Mzł -32.13Mzł -16.99Mzł -13.76Mzł 73.70M
Other Income/Expenses
zł 2.32Mzł 3.81Mzł -18.96Mzł 127.98Kzł -50.06K
Pretax Income
zł -31.29Mzł -28.37Mzł -15.26Mzł -13.64Mzł 73.65M
Net Income
zł -31.29Mzł -28.37Mzł -13.54Mzł -13.64Mzł 67.96M
Per Share Metrics
Basic EPS
zł -1.55zł -1.69zł -0.97zł -0.98zł 5.00
Diluted EPS
zł -1.55zł -1.69zł -0.97zł -0.98zł 4.90
Weighted Average Shares Outstanding
20.20M 16.84M 14.03M 13.95M 13.60M
Weighted Average Shares Outstanding (Diluted)
20.20M 16.84M 14.03M 13.95M 13.86M
Currency in PLN

OncoArendi Therapeutics SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis